Genetic markers predict response to antioxidants, zinc in AMD patients von Mullin, David W, Nale, Patricia

Volltext

HARBOR 2-year results support individualized dosing von Mullin, David W, Nale, Patricia

Volltext

Monthly, PRN doses of ranibizumab similarly effective in RVO von Mullin, David W, Nale, Patricia

Volltext

Plaque therapy achieves good local control in small choroidal melanomas von Mullin, David W, Nale, Patricia

Volltext

Noninvasive techniques promising for imaging diabetic macular edema von Mullin, David W, Nale, Patricia

Volltext

IVAN, CATT meta-analysis increases power of results von Mullin, David W, Nale, Patricia

Volltext

Study: Ocriplasmin treatment closed full-thickness macular holes in some patients von Mullin, David W, Nale, Patricia

Volltext

Study associates superior paracentral defect with disc hemorrhage von Mullin, David W, Nale, Patricia

Volltext

Attorney offers tips to lessen liability when prescribing off label von Mullin, David W, Nale, Patricia

Volltext

Repeating trinucleotide associated with ability to predict Fuchs' corneal dystrophy von Mullin, David W, Nale, Patricia

Volltext

Novel dry AMD treatment found safe, tolerable in phase 1b study von Mullin, David W, Nale, Patricia

Volltext

Phase 1b/2a study initiated with integrin peptide therapy for wet AMD von Mullin, David W, Nale, Patricia

Volltext

CNV development in fellow eye more active after first year of anti-VEGF treatment von Mullin, David W, Nale, Patricia

Volltext

'Real world' diabetic macular edema treatment outcomes lag behind trial outcomes von Mullin, David W, Nale, Patricia

Volltext

Normal tension glaucoma may be nocturnal disorder von Mullin, David W

Volltext

Lutein/zeaxanthin may not significantly reduce rate of cataract von Di Pietro, Cheryl, Mullin, David W, Nale, Patricia

Volltext

Two anti-VEGFs demonstrate no visual acuity difference at 2 years, CATT author says von Di Pietro, Cheryl, Mullin, David W, Nale, Patricia

Volltext

Alterations in AREDS formula recommended von Di Pietro, Cheryl, Mullin, David W, Nale, Patricia

Volltext

ARMOR study shows multi-drug resistance continues to be a challenge von Di Pietro, Cheryl, Mullin, David W, Nale, Patricia

Volltext

Carl Zeiss Meditec launches suite of OCT products von Biro, Ashley, Hasson, Matthew, Mullin, David W, Nale, Patricia

Volltext